Date published: 2026-5-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

VP 3.15 (CAS 1281681-54-6)

0.0(0)
Write a reviewAsk a question

Datasheets
Alternate Names:
VP315 VP-3.15
CAS Number:
1281681-54-6
Molecular Weight:
366.48
Molecular Formula:
C20H22N4OS
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

QUICK LINKS


VP 3.15 (CAS 1281681-54-6) References

  1. A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.  |  Martín-Álvarez, R., et al. 2017. J Chem Neuroanat. 80: 27-36. PMID: 28007551
  2. Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.  |  Medina-Rodríguez, EM., et al. 2017. Sci Rep. 7: 43545. PMID: 28256546
  3. Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa.  |  Sánchez-Cruz, A., et al. 2018. Mol Neurodegener. 13: 19. PMID: 29661219
  4. Dynamics of Central Remyelination and Treatment Evolution in a Model of Multiple Sclerosis with Optic Coherence Tomography.  |  Benítez-Fernández, R., et al. 2021. Int J Mol Sci. 22: PMID: 33671012
  5. The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis.  |  Benítez-Fernández, R., et al. 2022. Int J Mol Sci. 23: PMID: 36430856
  6. Glycogen Synthase Kinase-3β Inhibitor VP3.15 Ameliorates Neurogenesis, Neuronal Loss and Cognitive Impairment in a Model of Germinal Matrix-intraventricular Hemorrhage of the Preterm Newborn.  |  Atienza-Navarro, I., et al. 2024. Transl Stroke Res.. PMID: 38231413

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

VP 3.15, 10 mg

sc-507331
10 mg
$970.00